Endocrine System: DKA vs. HHS

Jun 19, 2024

Endocrine System: DKA vs. HHS

Introduction

  • Lecturer: Eddie Watson
  • Channel: ICU Advantage
  • Topic: Differences between Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)
  • Audience: Critical care students/professionals

Overview of DKA and HHS

  • Both are hyperglycemic emergencies requiring quick intervention and ICU monitoring.
  • Similarities involve acute hyperglycemia in decompensated diabetic patients.

Diabetic Ketoacidosis (DKA)

Key Characteristics

  • Primarily occurs in Type 1 diabetics (rare in Type 2).
  • Defined by:
    • Hyperglycemia: Glucose > 300 mg/dL
    • Hypovolemia
    • Ketoneemia and Ketonuria (ketones in blood and urine)
    • Anion gap metabolic acidosis

Lab Values

  • Glucose: > 300 mg/dL
  • Bicarb: < 15 mEq/L (can go < 10 in moderate, < 5 in severe)
  • pH: < 7.3 (can go < 7.2 in moderate, < 7.1 in severe)
  • Ketoneemia & Ketonuria

Causes

  • Newly diagnosed Type 1 diabetes
  • Insufficient insulin administration
  • Stressful events: infection, trauma, surgery, pregnancy, alcohol intoxication

Pathophysiology

  • Develops in < 24 hours
  • Trigger: Insufficient or absent insulin levels
  • Results:
    • Increased fatty acid metabolism → ketones production
    • Increased liver gluconeogenesis → glucose from proteins/amino acids
    • Secretion of counter-regulatory hormones (glucagon, catecholamines, cortisol, growth hormone)
    • Higher blood glucose but cellular glucose deprivation

Components

  1. Fluid Volume Deficit & Electrolyte Imbalance:
    • Osmotic pressure increase → fluid shift to extracellular space → osmotic diuresis
    • Loss of water, sodium, magnesium, calcium, and phosphorus
    • Risk of hypovolemic shock, decreased GFR, dehydration of brain cells (neurological symptoms)
  2. Acid-Base Imbalance:
    • Cellular starvation → fats & proteins metabolism → ketone acids → metabolic acidosis
    • Tissue hypoperfusion → anaerobic metabolism → lactic acid → worsened metabolic acidosis
    • Increased anion gap
    • Respiratory compensation: increased respiration rate & tidal volume
    • Intracellular potassium shift → potential hypokalemia

Signs and Symptoms

  • Acetone Breath: Fruity smell
  • Kussmaul Respirations: Rapid deep breathing
  • **Abdominal Pain, Nausea, Vomiting
  • Altered mental status: Paresthesia, paresis, aphasia
  • Other Symptoms: Tachycardia, polyuria, polydipsia, lethargy, stupor, unconsciousness

Hyperosmolar Hyperglycemic State (HHS)

Key Characteristics

  • Mostly seen in Type 2 diabetics
  • Severe hyperglycemia (600-2000 mg/dL, typically ~1100)
  • Profound dehydration, hyperosmolality, absence of ketosis
  • Progressive onset (weeks to months)

Pathophysiology

  • Partially functional insulin prevents lipolysis & ketones production
  • Higher osmotic pressure → higher diuresis → profound dehydration (9-10 liters deficit)
  • Less obvious symptoms delay treatment
  • Elevated glucose leads to osmotic diuresis and dehydration, but pH generally normal
  • Risk of lactic acid buildup due to hypoperfusion

Signs and Symptoms

  • CNS Dysfunction & Higher Mortality: Due to severe dehydration, often in chronically ill patients
  • Risks: Cardiac respiratory center depression, cerebral edema, cardiovascular collapse, renal shutdown, vascular embolism

Treatment for DKA and HHS

  • Similarities
    • Fluid replacement
    • Treating hyperglycemia
    • Electrolyte replacement
    • Treating underlying disorder

Fluid Replacement

  • Priority: Prevent cardiovascular collapse
  • Initial rapid bolus of 0.9% normal saline (1-3 liters in the first hour)
  • Continue fluids until volume restored
  • Switch to D5 half NS as glucose normalizes to avoid hypoglycemia
  • For DKA: Switch at glucose ~250 mg/dL; for HHS, higher to avoid cerebral edema

Hyperglycemia Treatment

  • IV insulin
  • Goal: Decrease glucose by 50-70 per hour
  • Continue insulin until normal pH to avoid intracellular hypokalemia
  • Monitor frequently (requires ICU care)

Electrolyte Replacement

  • Frequent monitoring of potassium, magnesium, calcium, and phosphorus
  • Hypokalemia risk: due to potassium shift and insulin administration
  • Replace based on serum levels
  • Monitor for signs of electrolyte imbalance

Underlying Disorder Treatment

  • Determine and treat precipitating event (often infection)

Summary

  • Understanding distinctions between DKA and HHS is crucial for effective treatment.
  • Focus on fluid replacement, hyperglycemia management, electrolyte balance, and root cause treatment.
  • Proper intervention can significantly improve patient outcomes and reduce mortality.

Conclusion

  • This concludes the lesson on DKA vs. HHS.
  • Upcoming lessons will cover differences between DI (Diabetes Insipidus) and SIADH (Syndrome of Inappropriate Antidiuretic Hormone).
  • Don't forget to subscribe and stay updated for new lessons.